Pharmacologic therapies for hypertrophic cardiomyopathy: The past, the present, and the future
{{output}}
Hypertrophic cardiomyopathy (HCM) stands as the most common monogenic cardiac disease, with an estimated prevalence historically reported as 1:500, but likely closer to 1:200 based on contemporary population studies in the general population. The past decade h... ...